Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)

SHE:300347 Revenue

Hangzhou Tigermed Consulting had revenue of 2.08B CNY in the quarter ending September 30, 2026, with 17.38% growth. This brings the company's total for the last twelve months to 7.60B, up 15.81% year-over-year. In the year 2025, Hangzhou Tigermed Consulting had annual revenue of 6.83B with 3.48% growth. That makes Hangzhou Tigermed Consulting the 7,067th largest company in the world by revenue and 1,017th in China.

• Revenue (ttm): 7.60B
• Revenue Growth: +15.81%
• P/S Ratio: 5.17
• Revenue / Employee: 634.05K
• Employees: 11,984
• Market Cap: 39.24B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Clinical Trial Related and Laboratory Services 3.45B 50.4%
• Clinical trial technical services 3.27B 47.8%
• Unallocated Other Business 119.47M 1.7%

By Geography

Chart

• China 3.71B 54.2%
• Overseas 3.13B 45.8%

Fiscal year ended Dec 31, 2025 See the full SHE:300347 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.83B	229.68M	3.48%
Dec 31, 2024	6.60B	-780.92M	-10.58%
Dec 31, 2023	7.38B	298.57M	4.21%
Jan 1, 2023	7.09B	1.87B	35.91%
Jan 1, 2022	5.21B	2.02B	63.32%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error